Hypertension and Afro-descendant ethnicity:: a bad interaction for lupus nephritis treated with cyclophosphamide?

被引:12
作者
de Castro, W. P.
Morales, J. V.
Wagner, M. B.
Graudenz, M.
Edelweiss, M. I.
Goncalves, L. F.
机构
[1] Univ Fed Rio Grande do Sul, Fac Med, Post Grad Program Med Sci Nephrol, BR-90046900 Porto Alegre, RS, Brazil
[2] Fundacao Fac Fed Ciencias Med, Dept Pathol, Porto Alegre, RS, Brazil
[3] Fundacao Fac Fed Ciencias Med, Dept Internal Med Nephrol, Porto Alegre, RS, Brazil
[4] Hosp Clin Porto Alegre, Div Nephrol, Porto Alegre, RS, Brazil
[5] Santa Casa Misericordia Porto Alegre, Div Nephrol, Porto Alegre, RS, Brazil
[6] Hosp Clin Porto Alegre, Div Pathol, Porto Alegre, RS, Brazil
关键词
cyclophosphamide; ethnicity; hypertension; lupus nephritis; prognosis;
D O I
10.1177/0961203307081114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension and ethnicity are important prognostic factors in evolution of lupus nephritis. A cohort of 75 patients with lupus nephritis treated with cyclophosphamide was conducted to investigate the evolution of creatinine levels between Caucasians and Afro-descendants. A multiple linear model was used to evaluate the combined effects of ethnicity and hypertension over delta creatinine controlling confounders. Sample characteristics were: 85% females; mean (+/- SD) age of 33.6 +/- 12.0 years; 77% Caucasians; 40% hypertensive at renal biopsy; 91% WHO class IV; mean basal creatinine: 1.5 +/- 1.3 mg/dL; mean final creatinine: 2.1 +/- 2.5 mg/dL; 40% anaemia; proteinuria: 5.4 +/- 4.8 g/day. Comparing Caucasians and Afro-descendants, it was found: 28.1% versus 72.2% for hypertension (P = 0.002); 31.6% versus 66.7% for anaemia (P = 0.018); 5.9 +/- 5.0 versus 3.8 +/- 4.0 g/day (P = 0.02) for proteinuria. Other comparisons including basal creatinine did not reach statistical significance. Comparing outcomes between Caucasians and Afro-descendants, it was found: 10.5% versus 22.2% for doubling of creatinine (P = 0.24); 0.41 +/- 2.03 versus 1.05 +/- 2.41 for delta creatinine (P = 0.29); 8.8% versus 22.2% for haemodialysis (P = 0.21) and 3.5% versus 5.6% for death (P = 0.99). Analysing delta creatinine with multiple linear regression showed that hypertension had a significant overall effect (b = 0.80; SE = 0.32; P = 0.015), ethnicity alone was not significant (b = 0.35; SE = 0.29; P = 0.228); however, the effect of hypertension on delta creatinine was more intense among Afro-descendants than among Caucasians (interaction term b = - 0.83; SE = 0.37; P = 0.027). Afro-descendants lupus patients experience worst prognosis of renal function probably due to the effect of hypertension and not ethnicity per se.
引用
收藏
页码:724 / 730
页数:7
相关论文
共 34 条
[1]  
Altman DG, 1991, PRACTICAL STAT MED R, P396
[2]   FACTORS ASSOCIATED WITH CHRONIC-RENAL-FAILURE IN 121 PATIENTS WITH DIFFUSE PROLIFERATIVE LUPUS-NEPHRITIS - A CASE-CONTROL STUDY [J].
ARCESALINAS, CA ;
VILLA, AR ;
MARTINEZRUEDA, JO ;
MUNOZ, L ;
CARDIEL, MH ;
ALCOCERVARELA, J ;
ALARCONSEGOVIA, D .
LUPUS, 1995, 4 (03) :197-203
[3]   PREDICTING RENAL OUTCOMES IN SEVERE LUPUS NEPHRITIS - CONTRIBUTIONS OF CLINICAL AND HISTOLOGIC DATA [J].
AUSTIN, HA ;
BOUMPAS, DT ;
VAUGHAN, EM ;
BALOW, JE .
KIDNEY INTERNATIONAL, 1994, 45 (02) :544-550
[4]  
AUSTIN HA, 1995, NEPHROL DIAL TRANSPL, V10, P1620
[5]  
AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75
[6]   THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS [J].
AUSTIN, HA ;
KLIPPEL, JH ;
BALOW, JE ;
LERICHE, NGH ;
STEINBERG, AD ;
PLOTZ, PH ;
DECKER, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) :614-619
[7]  
BALOW JE, 1984, NEW ENGL J MED, V311, P491, DOI 10.1056/NEJM198408233110802
[8]   Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity [J].
Barr, RG ;
Seliger, S ;
Appel, GB ;
Zuniga, R ;
D'Agati, V ;
Salmon, J ;
Radhakrishnan, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) :2039-2046
[9]   The very long-term prognosis and complications of lupus nephritis and its treatment [J].
Bono, L ;
Cameron, JS ;
Hicks, JA .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1999, 92 (04) :211-218
[10]   Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis [J].
Chan, TM ;
Li, FK ;
Tang, CSO ;
Wong, RWS ;
Fang, GX ;
Ji, YL ;
Lau, CS ;
Wong, AKM ;
Tong, MKL ;
Chan, KW ;
Lai, KN .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16) :1156-1162